Literature DB >> 12940796

How is medical decision-making shared? The case of haemophilia patients and doctors: the aftermath of the infected blood affair in France.

Emmanuelle Fillion1.   

Abstract

OBJECTIVE: This article looks at how users and doctors in France have rethought the question of shared decision-making in the clinical field of haemophilia following a major crisis - that of the infected blood affair.
DESIGN: We did a qualitative survey based on semi-structured interviews in three regions of France. SETTING AND PARTICIPANTS: The interviews covered 31 clinical doctors of haemophilia and 31 users: 21 adult males with severe haemophilia (21/31), infected (14/21) or not (7/21) with HIV, the infected wife of one of the latter (1/31) and nine parents of young patients with severe haemophilia (9/31), either HIV positive (6/9) or negative (3/9). RESULTS AND
CONCLUSIONS: The results show the infected blood affair to be a major individual and collective ordeal. It has caused users and doctors to rethink their roles within clinical relationships and to develop new ways of sharing medical decision-making. Prior to the crisis, the dominant model was based upon a distinction between the medical aspect, governed by the doctors, and the psychosocial aspect, which involved the patients and their families. Since the crisis, medicoscientific knowledge has been shared between users and doctors. This general trend nevertheless permits the existence of different patient, family and doctor profiles which in turn correspond to different notions of what a clinical decision should be. Some users remain attached to the idea of complementarity between doctors and patients (new partnership model), whilst others put doctors and patients on an equal footing (negotiation model). On the doctors' side, whilst some still prefer the initial model for therapeutic decision-making, the majority have reassessed their perceptions and viewpoints. A certain number believe that decisions should be made by both doctor and patient in accordance with scientific procedures (decision-making controlled by scientific standards) or regulatory procedures (decision-making controlled by legal standards). Yet others feel that multiple points of view are acceptable within the decision-making process (decision-making model as interactivity).

Entities:  

Mesh:

Year:  2003        PMID: 12940796      PMCID: PMC5060181          DOI: 10.1046/j.1369-6513.2003.00244.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  8 in total

1.  Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model.

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1999-09       Impact factor: 4.634

2.  Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial.

Authors:  Andrew D M Kennedy; Mark J Sculpher; Angela Coulter; Nuala Dwyer; Margaret Rees; Keith R Abrams; Susan Horsley; Deborah Cowley; Christine Kidson; Catherine Kirwin; Caroline Naish; Gordon Stirrat
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

3.  Impure science: AIDS, activism, and the politics of knowledge.

Authors:  S Epstein
Journal:  Med Soc (Berkeley)       Date:  1996

4.  Sharing decisions with patients: is the information good enough?

Authors:  A Coulter; V Entwistle; D Gilbert
Journal:  BMJ       Date:  1999-01-30

5.  The patient's view.

Authors:  D Armstrong
Journal:  Soc Sci Med       Date:  1984       Impact factor: 4.634

Review 6.  Partnerships with patients: the pros and cons of shared clinical decision-making.

Authors:  A Coulter
Journal:  J Health Serv Res Policy       Date:  1997-04

7.  Evaluation of the quality of patient information to support informed shared decision-making.

Authors:  W Godolphin; A Towle; R McKendry
Journal:  Health Expect       Date:  2001-12       Impact factor: 3.377

8.  Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions.

Authors:  Mark Sculpher; Amiram Gafni; Ian Watt
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

  8 in total
  4 in total

1.  Does an information leaflet about surgical site infection (SSI) improve recollection of information and satisfaction of patients? A randomized trial in patients scheduled for digestive surgery.

Authors:  Véronique Merle; Hélène Marini; Julie Rongère; Marie-Pierre Tavolacci; Michel Scotté; Pierre Czernichow
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 2.  The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries.

Authors:  Fadi Nossair; Courtney D Thornburg
Journal:  Ther Adv Hematol       Date:  2018-07-02

3.  Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study.

Authors:  Daniel P Hart; Brian R Branchford; Sarah Hendry; Robert Ledniczky; Robert F Sidonio; Claude Négrier; Michelle Kim; Michelle Rice; Matthew Minshall; Claire Arcé; Steve Prince; Maria Kelleher; Sharon Lee
Journal:  Orphanet J Rare Dis       Date:  2021-04-28       Impact factor: 4.123

Review 4.  Measuring therapeutic relationship in the care of patients with haemophilia: A scoping review.

Authors:  Erin McCabe; Maxi Miciak; Liz Dennett; Patricia Manns; Christine Guptill; Jeremy Hall; Douglas P Gross
Journal:  Health Expect       Date:  2018-08-29       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.